We are live on
!
Find out more
BFS
Bradley Foster & Sargent Portfolio holdings
AUM
$6.44B
1-Year Est. Return
25.27%
This Fund
S&P 500
This Quarter
Est. Return
+11.21%
1 Year Est. Return
+25.27%
3 Year Est. Return
+77.25%
5 Year Est. Return
+101.72%
10 Year Est. Return
–
AUM
$3.41B
AUM Growth
–
Cap. Flow
+$3.34B
Cap. Flow
% of AUM
97.97%
Top 10 Holdings %
Top 10 Hldgs %
30.32%
Holding
339
New
339
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$174M |
| 2 |
Apple
AAPL
|
+$146M |
| 3 |
Danaher
DHR
|
+$110M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$89.6M |
| 5 |
JPMorgan Chase
JPM
|
+$88.4M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.15% |
| 2 | Healthcare | 18.73% |
| 3 | Financials | 10.45% |
| 4 | Consumer Discretionary | 9.61% |
| 5 | Consumer Staples | 9.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
New Oriental
EDU
$8.82B
| $374K | 0.01% |
+2,500
| New | +$361K |
|
277
Lincoln Electric
LECO
$15.5B
| $374K | 0.01% |
+4,060
| New | +$374K |
|
278
Edwards Lifesciences
EW
$54B
| $368K | 0.01% |
+4,614
| New | +$360K |
|
|
UN
279
DELISTED
Unilever NV New York Registry Shares
UN
| $362K | 0.01% |
+5,998
| New | +$348K |
|
280
Fate Therapeutics
FATE
$316M
| $361K | 0.01% |
+9,020
| New | +$315K |
|
281
Dover
DOV
$28.1B
| $359K | 0.01% |
+3,316
| New | +$355K |
|
282
Zscaler
ZS
$28.9B
| $355K | 0.01% |
+2,520
| New | +$327K |
|
283
Vanguard Morningstar Small-Cap ETF
VB
$82.8B
| $352K | 0.01% |
+2,286
| New | +$351K |
|
284
Cognizant
CTSH
$26.4B
| $343K | 0.01% |
+4,936
| New | +$321K |
|
285
Northern Trust
NTRS
$34.3B
| $342K | 0.01% |
+4,381
| New | +$352K |
|
286
Nkarta
NKTX
$168M
| $334K | 0.01% |
+11,096
| New | +$327K |
|
287
iShares Russell 1000 Value ETF
IWD
$84.1B
| $333K | 0.01% |
+2,816
| New | +$334K |
|
288
HP
HPQ
$26.6B
| $332K | 0.01% |
+17,491
| New | +$319K |
|
289
Cullen/Frost Bankers
CFR
$10.4B
| $328K | 0.01% |
+5,125
| New | +$359K |
|
290
Equinix
EQIX
$102B
| $328K | 0.01% |
+432
| New | +$327K |
|
291
J.M. Smucker
SJM
$12.6B
| $327K | 0.01% |
+2,828
| New | +$315K |
|
292
Microchip Technology
MCHP
$44.1B
| $324K | 0.01% |
+6,300
| New | +$328K |
|
293
Elevance Health
ELV
$84.3B
| $313K | 0.01% |
+1,167
| New | +$314K |
|
294
Cytosorbents Corp
CTSO
$22.9M
| $312K | 0.01% |
+39,140
| New | +$353K |
|
295
State Street SPDR S&P Dividend ETF
SDY
$22.1B
| $312K | 0.01% |
+3,374
| New | +$318K |
|
296
State Street Financial Select Sector SPDR ETF
XLF
$59.1B
| $309K | 0.01% |
+12,836
| New | +$312K |
|
297
RPM International
RPM
$14.9B
| $306K | 0.01% |
+3,700
| New | +$302K |
|
298
SLB Ltd
SLB
$79.3B
| $306K | 0.01% |
+19,661
| New | +$366K |
|
299
Aflac
AFL
$60.9B
| $305K | 0.01% |
+8,392
| New | +$306K |
|
300
Corteva
CTVA
$51.1B
| $301K | 0.01% |
+10,459
| New | +$294K |
|
Similar funds
PCH
HI
TCM
CG
EWM
EC
LAM
OCM
Bradley Foster & Sargent's Q3 2020 Portfolio in Review
Q3 2020 is the first quarter with a 13F filing on record for Bradley Foster & Sargent, which disclosed 339 positions worth $3.41B. Its ten largest holdings account for 30% of the portfolio.
Its largest position is Microsoft: 830,056 shares worth $175M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, followed by Healthcare and Financials.
- Bradley Foster & Sargent's largest Q3 2020 buy was Microsoft: 830,056 shares worth $175M.
- Bradley Foster & Sargent's ten largest holdings make up 30% of its $3.41B portfolio in Q3 2020.
- Bradley Foster & Sargent disclosed 339 positions in Q3 2020, its first 13F filing on record.
Based on Bradley Foster & Sargent's 13F filing for Q3 2020, filed 26 Oct 2020.